Constellation Brands at 9.6x Forward Earnings: A Premium-Beer Litmus Test the Market Already Thinks It's Failing

The trade-down signal in U.S. alcohol isn't a forecast anymore — it's a Q1 2026 print. Per WSWA SipSource data cited in the trade press, U.S. spirits volume fell 5.1% and revenue fell 5.9% in Q1 2026, with the steepest declines hitting the top of the shelf: bottles priced $50–$99.99 dropped 8.8% in volume and bottles above $100 fell 9.3%. Tequila and agave specifically were down 3.0% in volume and 6.6% in revenue — a sharp reversal from the year-ago period, when luxury tequila revenue was still growing 4.2%.

Beer is in a milder version of the same trade-down. Molson Coors management put U.S. beer industry volume at -4.2% in its calendar Q2 2026 (period ended June 30, 2026), per its Aug. 6, 2026 earnings release. Against that backdrop, Anheuser-Busch InBev still grew global beer volumes +1.1% on +5.6% revenue in its Q2 2026 print, and U.S. super-premium domestic beer led Circana's Q1 2026 dollar-share gainer list — meaning the premium end of the set is still gaining at the expense of mainstream, not of premium itself.

Beer generates the bulk of Constellation Brands' economics. For fiscal 2026 (ended Feb. 28, 2026), the beer segment did $8.32B in net sales, 91% of the $9.14B company total, on 415.4M case-equivalent shipments. Beer operating margin was 38.0% — a 170 basis-point year-over-year compression — and operating income fell 7% to $3.16B even as net sales fell only 3%, because depletions dropped 2.1% while shipments fell 3.8%.

The mix inside the beer portfolio is the real signal. In Q1 fiscal 2027, total beer depletions fell just 0.3% — but only because growth in the secondary portfolio absorbed Modelo and Corona weakness. Modelo Especial, the brand that built the modern Constellation story, was down 2%; Corona Extra was down 5%. Pacifico rose 21%, Victoria rose 14% and Modelo Chelada rose 6%, per the Q1 FY2027 release. Management's Sept. 13, 2026 investor update described \"strong on-premise performance and World Cup share gains\" against \"lackluster off-premise results\" — the same trade-down pattern, expressed inside the company's own portfolio.

Two forces outside the company's control are converging on the same brand family. The Trump administration's 25% tariff on imported canned beer landed in 2025, and a separate 25% tariff on aluminum hits the can itself. In a July 2025 disclosure, Constellation Brands said the canned-beer tariff alone would cost roughly $20 million over the coming months. The Teamsters have since lobbied publicly for a 75% tariff on Mexican beer, framing it as a U.S. jobs measure — an escalation the market is pricing as a tail risk.

On the demand side, CEO Bill Newlands has repeatedly tied softer beer sales to strain on Hispanic consumers, the core demographic for Modelo and Corona. Per the company's April 2025 commentary and Q2 FY2026 earnings call (Oct. 6, 2025), immigration-enforcement pressure has coincided with weaker off-premise takeaway in Hispanic-dense markets. The Q1 FY2027 depletion pattern — Modelo down, Corona down, Pacifico up — fits the same story: Mexican-heritage consumers trading down inside the Mexican category to a lower-priced entry point.

The Q1 FY2027 segment decline looks alarming on the surface: Wine & Spirits net sales fell 47% to $149.2 million. But that collapse is a designed outcome, not a demand failure. In April 2025, Constellation Brands signed a definitive agreement to divest roughly 12 million cases of mainstream wine brands to The Wine Group. Earlier, in April 2024, the company sold its remaining mainstream U.S. wine business to E&J Gallo for $430.6 million. Svedka vodka and Copper & Kings brandy have also been divested, per The Spirits Business coverage of the FY2026 results.

What remains is a deliberately smaller, higher-margin portfolio: Casa Noble and Mi Campo tequilas, High West and Noble Oak whiskeys, and higher-end wine labels including The Prisoner and Kim Crawford. Depletions in the residual Wine & Spirits business actually rose 6.6% in Q1 FY2027, with Casa Noble and other premium tequila brands up 62%, per Shanken News Daily coverage of the release. The 47% revenue collapse is a denominator effect — the lowest-margin brands are gone, not the highest-margin ones.

Consensus is $2.57 billion in net sales (+3.6% YoY) and $3.62 in comparable EPS, essentially flat against $3.63 a year earlier. That +3.6% revenue bar sits uncomfortably above Q1 FY2027's actual -3.3% net-sales decline. To clear it, Constellation Brands needs a combination of three things: better Modelo and Corona depletions in August, year-over-year shipment normalization as distributors rebuild inventory, and continued on-premise momentum around the FIFA World Cup window.

Beer operating margin is the second test. Management's full-year FY2027 beer-margin guide is 37% to 38% — at the low end, the same 170-basis-point compression fiscal 2026 absorbed. In the Q2 FY2026 print a year ago, beer operating margin was already pressured by inflation and marketing reinvestment, and management has flagged additional logistics and commodity inflation for the second half of FY2027 (per Barclays conference commentary, Sept. 8, 2026). A margin print at the upper end of the guide would suggest the $200 million annualized restructuring savings (targeted by fiscal 2028) are showing up early; a print below 37% would suggest pricing power is bending.

STZ closed at $112.99 on Oct. 1, down 13.5% from $130.62 on Aug. 31. The forward P/E of roughly 9.6x is unusual for a consumer-staples beverage company with a 38% beer operating margin and a buyback-funded capital-return program — it sits closer to a cyclical-trough multiple than a defensive-staples multiple. The market is pricing some combination of: a beer-volume recession, persistent tariff escalation, and a structural reset in trade-down elasticity. The Sept. 8, 2026 redemption notice for $600 million of 4.350% senior notes due 2027 — funded out of cash on hand — tells a complementary story: management has the balance sheet, but is paying down near-term paper anyway.

The peer set is hardly roaring. Brown-Forman's fiscal 2026 results (ended April 30, 2026) guided to roughly flat organic net sales and a 3–5% organic operating-income decline. Diageo's fiscal 2026 preliminary results (year ended June 30, 2026) showed reported net sales down 3.0% to $19.6B and operating profit down 27.2%. The U.S. premium-spirits category isn't a STZ problem alone; it is a category-wide re-rate. The bull case for STZ is that beer is more defensible than premium spirits and that the operating-margin floor is higher than the multiple implies. The bear case is that beer depletions turn negative in Q2 FY2027 and the multiple compresses toward cyclical-stock territory.

The transmission mechanism into the supply chain runs through packaging, ingredients, and distribution. Crown Holdings and Amcor supply the aluminum cans and glass bottles that move beer and spirits volume; an extended period of negative depletions at STZ would hit can-volume forecasts, while a recovery would pull them forward. MGP Ingredients sits on the spirits-input side — the agave-price crash (down more than 90% from 2022 peak) is margin-supportive for any tequila brand, including STZ's Casa Noble and Mi Campo, even as category volumes soften.

On the off-trade retail side, Walmart and Target have flagged their own QSR-adjacent trade-down in 2026 earnings — premium alcohol is the same household-budget decision. The 25% canned-beer tariff and Hispanic-consumer pressure also create share-shift opportunities: if Modelo and Corona stay weak, AB InBev's domestic portfolio (Bud Light, Michelob Ultra) and its import brands (Stella Artois, Pacifico directly competes with STZ) become the marginal beneficiaries. Diageo, the world's largest spirits company and owner of Casamigos and Don Julio tequila, is the cleanest cross-asset read on whether the U.S. tequila trade-down stabilizes — and STZ's residual Casa Noble/Mi Campo niche inherits some of the same tailwinds or headwinds.